MMP2 and myocardial ischemia: However, Doxy (submicrobial doses) has been shown to significantly reduce cardiac MMP-2 activity in the clinical trial in patients undergoing artery bypass graft surgery with cardiopulmonary bypass (cardiac ischemia/reperfusion injury) [43].